Upcoming Stock Splits This Week (April 27 to May 1) – Stay Invested

These are the upcoming stock splits for the week of April 27 to May 1, based on TipRanks’ Stock Splits Calendar. A stock split is a corporate action aimed at improving share accessibility. While the company’s overall market value remains unchanged, the number of shares increases and the price per share declines, which can support liquidity and make the stock more attainable for a wider investor base.

That is the traditional approach. In today’s market, however, many splits tend to go the other way. A reverse stock split reduces the number of shares outstanding through consolidation, lifting the price per share without changing the company’s overall valuation. These moves are most often driven by regulatory pressures, particularly the need to maintain minimum price thresholds on exchanges such as Nasdaq and avoid the risk of delisting.

Rather than changing the underlying value, stock splits in either direction often send a message. They can hint at how management views the stock’s current trading range and what it believes is needed to better align the share price with market expectations.

Let’s take a look at the upcoming stock splits for the week.

Wheels Up Experience (UP) – Wheels Up Experience is a provider of on-demand private aviation, offering membership programs, charter services, and integrated travel solutions through a network of owned and third-party aircraft. The company operates a large fleet of light and midsize jets and maintains a strategic partnership with Delta Air Lines, allowing members to access both private and commercial travel options through a unified platform. On April 14, Wheels Up announced a 1-for-20 reverse stock split as part of its effort to meet the NYSE’s minimum bid price requirement and maintain compliance with listing standards. The split took effect on April 24, with shares beginning to trade on a split-adjusted basis on April 27.

Immunic, Inc. (IMUX) – Immunic is a clinical-stage biotechnology company focused on developing oral therapies for chronic inflammatory and autoimmune diseases, with its lead candidate targeting multiple sclerosis and other immune-driven conditions. The company is advancing a pipeline centered on small molecules designed to modulate immune responses while maintaining favorable safety profiles. On April 23, Immunic announced a 1-for-10 reverse stock split as part of its effort to maintain compliance with Nasdaq’s listing standards. The split is set to take effect on April 27.

Aios Tech (AIOS) – Aios Tech is a China-based company that develops AI-driven solutions designed to enhance business operations through automation, data analytics, and digital transformation tools. The company targets enterprise clients seeking to integrate AI into workflow optimization and decision-making processes. On April 21, Aios Tech announced a 1-for-20 reverse stock split as part of its effort to maintain compliance with Nasdaq’s listing standards. April 27 is when the split is expected to take effect.

Oriental Culture Holding (OCG) – Oriental Culture Holding is a Hong Kong-based company that operates an online platform focused on trading collectible artwork, cultural assets, and commodities, primarily serving the Chinese market. The company integrates e-commerce and financial services to facilitate transactions in niche cultural investment categories. On April 3, the company approved a 1-for-3 share consolidation to comply with Nasdaq’s minimum bid price requirement under listing standards. The split will take effect on April 27.

Direct Digital Holdings (DRCT) – Direct Digital Holdings operates a programmatic advertising platform that connects advertisers with publishers through data-driven targeting solutions, serving industries such as healthcare, travel, and financial services. Through its Colossus SSP and Orange 142 segments, the company focuses on delivering measurable campaign performance across digital channels. On April 23, Direct Digital announced a 1-for-4 reverse stock split to meet Nasdaq’s minimum bid price requirement. April 27 has been set as the expected effective date for the split.

C3is Inc. (CISS) – C3is is a Greece-based shipping company engaged in the ownership and operation of dry bulk vessels, transporting commodities such as iron ore, coal, and grains across international trade routes. The company focuses on fleet expansion and operational efficiency within the maritime logistics sector. On April 23, C3is announced a 1-for-7 reverse stock split to comply with Nasdaq’s minimum bid price requirement. The split will take effect today at 11:59 p.m. Eastern Time, with shares set to begin trading on a split-adjusted basis tomorrow, April 27.

iSpecimen Inc. (ISPC) – iSpecimen operates a technology-driven marketplace that connects researchers with healthcare providers to source human biospecimens for medical research and clinical trials. The company’s platform supports advancements in diagnostics, drug development, and precision medicine. On April 24, iSpecimen announced a 1-for-40 reverse stock split to stay in compliance with Nasdaq’s listing standards. The split will take effect on April 27, with shares set to begin trading on a split-adjusted basis on April 28.

Diginex Limited (DGNX) – Diginex is a UK-based digital asset financial services and sustainability technology company offering blockchain-driven solutions, including ESG reporting platforms and digital asset infrastructure tools for institutional clients. The company operates across global markets, combining fintech innovation with regulatory-focused transparency solutions. On April 24, Diginex announced via an OCC notice a 1-for-8 reverse stock split to stay in compliance with Nasdaq’s listing standards. The split will take effect before the market opens on April 28.

VolitionRx Limited (VNRX) – VolitionRx is a life sciences company developing blood-based diagnostic tests aimed at early detection of cancer and other diseases through its proprietary Nu.Q platform. The company collaborates with academic institutions and commercial partners to expand its diagnostic applications across multiple healthcare markets. On April 17, VolitionRx announced via a Form 8-K a 1-for-20 reverse stock split, in part to comply with Nasdaq’s listing standards and in connection with financing-related considerations. Management expects the split to take effect on April 28.

BrainsWay Ltd. (BRAI) – BrainsWay is a neuroscience company specializing in non-invasive neurostimulation treatments for mental health disorders using its Deep TMS technology. The company markets FDA-cleared systems for conditions such as depression and obsessive-compulsive disorder, with growing adoption in clinical settings. On April 10, BrainsWay announced a 1-for-3 forward stock split to make its shares more accessible to retail investors. The split is expected to kick in on April 29.

To find more information about historical and upcoming stock splits, visit the TipRanks Stock Splits Calendar.